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Attempts to  immunize susceptible animals with  non-living material derived  from 
protozoan parasites have yielded conflicting  and sometimes inconclusive  results.  Wen- 
yon  (1)  states  that  injection  of killed  trypanosomes into  experimental animals may 
stimulate the production of complement-fixing and agglutinating antibodies, but that 
the existence of active immunity to infection has not been conclusively demonstrated. 
Schilling  (2), Braun and Teichmann (3), and Ponselle  (4) were able to produce active 
immunity to infection and to demonstrate protective antibodies in the serum of rats, 
mice, and guinea pigs after injection of killed preparations of Trypanosoma  brucei and 
T. equiperdum.  A more detailed review of this work will be found in the book by Talia- 
ferro (5).  The Sergents (6) reported that 29 per cent of a group of canaries were resistant 
to infection with Plasmodium praecox after the birds had been inoculated with sporozoites 
which were presumably killed by storage for 24 to 48 hours after being removed from the 
mosquitoes.  Only 0.72 per cent of a group of normal canaries were resistant to infection 
with  the parasite. 
It is possible that in some of the experiments just mentioned the immunity resulted 
from an inapparent infection with living organisms.  In the case of P. knowlesi infection 
in rhesus monkeys it appears that between one and five parasites are capable of producing 
infection, and that once the infection is established, it is almost invariably fatal unless 
treated (7).  For this reason the production of active immunity in rhesus monkeys by a 
sublethal dose of P. knowlesi seems to be impossible. 
The experiments described in this paper were performed for the purpose 
of finding  out  whether  or  not  complement-fixing,  agglutinating,  and  pro- 
tective antibodies,  and active immunity could be produced in rhesus mon- 
keys  by  intraperitoneal  or  intravenous  injection  of  non-living  antigens 
prepared from P.  knowlesi. 
Materials and Methods 
Parasitized blood was obtained by the methods described in a  previous paper (8). 
Five different methods were used to kill the parasites for the preparation of the vaccines. 
1.  The washed parasites were suspended in saline,  and 1 per cent of formaldehyde 
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was added.  The pH was adjusted to 7.4 with phosphate buffer and the preparation 
stored in the ice box. 
2.  A suspension of washed parasites in saline was heated at 56°C. for 30 minutes and 
then stored in the ice box. 
3.  The washed parasitized cells were dried in the frozen state in pyrex glass tubes in 
a vacuum desiccator.  The tubes were then sealed and stored in the ice box.  Just before 
making the injections the dried material was rehydrated with saline and, if to be given 
intravenously,  it  was filtered  through cotton.  In some experiments  whole blood of 
monkeys dying from infection with P. knowlesi was dried in the frozen state, and this 
was rehydrated with normal monkey serum. 
4.  The washed parasitized cells were laked with distilled water and the stroma and 
parasites  centrifuged down.  This concentrated material was then frozen and thawed 
four times  and finally stored in the frozen state  in the freezing compartment of the 
ice box. 
5.  Parasites were killed by incubation with the serum of a  rabbit immunized with 
P. knowlesi according to the method described in the preceding paper (9). 
Antigens prepared by the first four methods were injected intravenously or intra- 
peritoneally in doses of 2 to 5 cc., containing the equivalent of approximately 500 million 
to 2 billion parasites.  No infections were observed in twelve monkeys inoculated re- 
peatedly  with  these  vaccines.  As  indicated  in  the  previous  paper,  infections  were 
relatively frequent with vaccines prepared by the fifth method.  With these preparations 
only small doses of 100,000 to 1,000,000 parasites could be injected at one time. 
Three to four injections were given at intervals of 3 to 7 days, and after a period of 2 
weeks the animals were bled from the femoral vein to obtain  serum for complement 
fixation and agglutination  tests.  The injections  and bleeding were then  repeated  as 
before.  Complement  fixation  and  agglutination  tests  were  done  according  to  the 
methods described in previous papers  (8,  10). 
EXPERIMENTAL 
The  results  of injecting  into  monkeys parasites  killed  by  the  first  four 
methods  described  in the previous  section  are presented  in  Table  I. 
Monkeys 35, 36, and 37, which received formalinized parasites, developed low titers 
of complement-fixing antibodies after  1 to 1½  months.  After  further  injections  these 
antibodies tended to fall off or disappear completely.  The animals receiving heated or 
dried parasites, Nos. 38 to 44 inclusive, developed complement-fixing antibodies ranging 
in titer from 1:16 to 1:64.  These appeared about 1 month after the first injections and 
gradually increased to a maximum at 2 to 3 months.  Monkeys 45 and 46 received in- 
jections of frozen and thawed parasites.  The development of complement-fixing anti- 
bodies by these animals was delayed, and the titers were low.  There was no significant 
difference between the effects  of intraperitoneal and intravenous injection. 
Agglutination tests were done repeatedly with sera taken at various dates 
from all the monkeys in Table I.  In no case were agglutinins demonstrated 
(8).  At  the  end  of  the  course  of injections  the  animals  were  tested  for 
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TABLE  I 
Production of  Complement-Fixing Antibodies  in  Monkeys  by  Injection  of  Killed 
Parasites 
Monkey 
No. 
35 
36 
37 
38 
39 
40 
41 
42* 
43* 
44* 
45 
46 
Method of killing 
parasites 
Formalin 
lc 
Heat 
Dried 
lc 
Frozen and thawed 
Route of injection 
Intraperitoneal 
Intravenous 
Intraperitoneal 
Intravenous 
Intraperitoneal 
Intravenous 
gc 
c¢ 
Intraperitoneal 
Number of 
injections 
9 
9 
10 
9 
9 
10 
9 
16 
16 
18 
9 
9 
Period 
mo$. 
3 
3½ 
2 
3 
3½ 
2 
3 
5 
5 
7½ 
3 
3½ 
Complement-fixlng 
antibodies 
Maximum  Time to 
titer  maximum 
mo$. 
1:6  1 
1:4  1½ 
1:2  1 
1:32  2½ 
1:16  2 
1:64  2 
1:64  2½ 
1:32  2 
1:32  2 
1:32  3 
1:6  3 
1:4  3 
* Monkeys 42,  43,  and  44 received dried whole parasitized blood rehydrated with 
serum. 
TABLE  II 
Attempts to Produce Immunity by Injection of Parasites Killed with Immune Rabbit 
Serum 
Monkey No.  Number of injections  Period of  and parasites  immunization  Result of test for active immunity 
47* 
48 
49 
50 
51" 
52* 
53* 
54* 
55* 
56* 
1 X 10,000 
1 X 100,000 
6 X 100,000 
7 X  100,000 
1 X  1,000,000 
6 X  100,000 
2 X 1,000,000 
1 X 100,000 
4 X 100,000 
1 X 100,000 
3 X 100,000 
2 X 1,000,000 
3 X 100,000 
2 X 1,000,000 
1 X 100,000 
~05. 
1 
1½ 
3 
5 
½ 
3 
½ 
2 
2 
½ 
Survived after severe infectiont 
Died 28 dayst 
Died 20 days 
Survived after moderate  infectiont 
Died 13 days 
Died 18 days 
Died 10 days 
Died 14 days 
Died 15 days 
* Animals became infected after receiving an injection of parasites and rabbit serum 
in which all parasites had not been killed (not shown in second column of table).  Others 
were tested for immunity by injecting 10,000 living parasites. 
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died  with  acute  malaria,  the  only  exception  being  monkey  35.  This 
animal survived after a severe infection and died several months later with 
tuberculosis. 
Effect of Inoculating Monkeys Repeatedly  with Small Doses of 
Parasites and Immune Rabbit Serum 
Ten monkeys  were given intraperitoneal injections of a mixture of 1 cc. of serum from 
a rabbit immunized  with P. knowlesi  and 1 cc. of a dilution of parasites in whole  citrated 
monkey blood which had been incubated for 30 minutes at 37°C.  The injections were 
repeated at intervals of 1 to 2 weeks.  The sera of these monkeys  were tested for comple- 
ment-fixing  and agglutinating antibodies, but no significant  reactions in either test were 
found at any time during the course of injections. 
In  these  experiments an  attempt was  made  to  build  up  an immunity 
gradually by increasing the  dose of  parasites  first to  1,000,000,  then to 
10,000,000.  As a result of this procedure seven of the ten monkeys became 
infected before  the  course  of  immunization was  completed.  The  other 
three were tested for immunity after six to eight injections by infecting 
them with 10,000 living parasites.  The results are presented in Table II. 
Three of the ten monkeys, Nos. 47, 48, and 51, survived infection with P. knowlesi. 
No. 47 had received only two injections and No. 51 only one injection, and both these 
animals later died of tuberculosis.  No. 48 received six injections, survived the test for 
immunity, and has remained  well.  One other animal, No. 49, showed  a slightly increased 
resistance as indicated by survival for 28 days after infection with 10,000 parasites. 
This animal appeared to be recovering but later died with a high parasite count and 
tuberculous peritonitis.  The remaining six monkeys, Nos. 50, 52, 53, 54, 55, and 56, 
showed no significant  resistance to malarial infection. 
DISCUSSION 
The  relative  ease  with  which  complement-fixing  antibodies  against 
P. knowlesi can be produced in rabbits (9) and in monkeys by the injection 
of parasites killed by heat or drying, contrasted with the failure to produce 
significant amounts of protective antibodies in rabbits and active immunity 
in  monkeys,  suggests  at  once  that  separate  immunity mechanisms  are 
involved.  The  malarial  complement-fixing  antigen  behaves  like  other 
antigenic substances when injected into animals in that the production of 
antibodies is stimulated quite promptly, but the appearance of complement- 
fixing antibodies is  not  accompanied by  the production of agglutinating 
antibodies or protective antibodies.  Furthermore, the complement-fixing 
antibody appears to be group specific,  since reactions may be obtained with 
P. knowlesi antigen and sera from human beings infected with P. vivax or 
P. falciparum,  while  active  immunity to  malaria  appears  to  be  strictly 
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The  antigenic  component  of  the  parasite  concerned in  agglutination 
appears  to  be  different  from  that  taking  part  in  complement fixation. 
The lability of  the  agglutinating antigen has  been  indicated by  studies 
previously reported (8) in which it was found that only fresh preparations 
of  parasites  gave  definite  agglutination with  monkey  serum.  Parasites 
which have been dried and rehydrated do not agglutinate or precipitate with 
immune serum but  do  give  good fixation  of  complement.  The  soluble 
complement-fixing antigen found in the serum of monkeys infected with 
P. knowlesi (12) also appears to be distinct from the antigen concerned in 
agglutination.  These observations are supported by the finding reported 
in the present paper.  The injection of parasites killed by drying stimulates 
the production of complement-fixing antibodies to a high titer but does not 
produce agglutinins. 
In  the  experiments  on  active  immunization of  monkeys injection of 
parasites  killed by  heat,  freezing and  thawing,  formalin,  or  drying ap- 
parently produced no resistance whatever to infection with living parasites. 
The results with the first five monkeys inoculated with parasites and im- 
mune rabbit serum seemed promising, but three of these animals had tuber- 
culosis, and this apparently increased the resistance of monkeys to malaria. 
Further experiments with monkeys having no tuberculosis failed to confirm 
the earlier results.  The failure of these animals to produce complement- 
fixing antibodies was probably due to the relatively small doses of parasites 
given. 
The antigen concerned in the production of protective antibodies may 
be so labile both in vitro and in vivo that it is destroyed, under most condi- 
tions, when the parasite is killed.  Lability of the antigen to heat, formalin, 
drying, and freezing and thawing would account for the failure to produce 
protective  antibodies  in  monkeys with killed parasites.  In  the  experi- 
ments with rabbits injection of live parasites which should contain intact 
antigen  produces no  protective  antibodies.  In  order  to  explain  this  it 
would be necessary to postulate the destruction of the antigen at the same 
time as the parasite in the body of the rabbit. 
Quantities of antigen concerned in immunity by infection and in artificial 
immunization must also be considered.  In an infected monkey having a 
parasite count of 500 per 10,000 red cells there are approximately 25 billion 
circulating parasites, and at least this number is reproduced every 24 hours. 
Thus the amount of antigen produced in the body of an infected monkey 
over a period of a week may be conservatively estimated at several hundred 
times the amovat contained in several doses of  1 billion killed parasites. 
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differences in the amount of antigen available in infection and in artificial 
immunization would be even greater.  In the experiments described in this 
paper the injection of killed parasites was continued over a period of several 
months in the hope that by repeated small stimuli the quantitative differ- 
ences just discussed might be overcome. 
Taliaferro  (5)  and  others  have  called  attention  to  cellular  factors  in 
immunity to malaria.  Of these the great increase in phagocytic activity 
in the spleen seems to be the most important.  This form of resistance is 
presumably brought about only by infection.  However, the work of Cog- 
geshall and Kumm (13) emphasized the importance of circulating protective 
antibodies  in  immunity  of  monkeys to  infection  with  P.  knowlesi.  So 
far these protective antibodies have been produced in significant amounts 
only by infection, and their production is not brought about by injecting 
killed  parasites  into  susceptible  monkeys  or  living  parasites  into  non- 
susceptible  rabbits  according to  the  methods  described in  this  and  the 
preceding paper. 
SUM-~ARY 
Injection  into  rhesus  monkeys of Plasmodium  knowlesi  killed by heat, 
formalin,  drying, or  freezing and  thawing  stimulates  the  production  of 
complement-fixing antibodies,  but no demonstrable agglutinating or pro- 
tective antibodies are formed. 
Possible  differences in  the  immunity mechanisms concerned in  active 
infection and in artificial immunization are discussed. 
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